Key facts
- Hexin Medical’s last known valuation is $465.0M (Jun 2025).
- It has raised $174.7M; the latest was IPO in Nov 2025.
- Notable investors include GL Ventures, CICC Capital, Puhua Capital, Legend Capital, Co-Stone Capital — 17 tracked in total.
- Status: In IPO Registration.
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Hexin Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hexin Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hexin Medical
Manufacturer and developer of a magnetic levitation artificial heart designed for heart failure patients. The company focuses on the research and development of artificial hearts and ventricular assist medical devices, providing patients with small-size, lightweight, low-power consumption hearts.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2016
- Website
- coretechmed.com/
- Ownership
- In IPO Registration
Hexin Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hexin Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hexin Medical in its N-PORT filings yet. We sweep new filings monthly.